ABSTRACT Ten patients with endobronchial metastasis from primary breast cancer were found among 1200 fibreoptic bronchoscopies. Six of these patients had radiological signs suggesting bronchial obstruction. All the bronchoscopies were performed by us using the standard transnasal approach4 with either the Olympus BF5B2 or BFB2 fibreoptic bronchoscope. Topical anaesthesia with 1 % lignocaine was used. Atropine 0-8 mg intramuscularly was given before the procedure.
Endobronchial metastasis from nonpulmonary carcinoma is uncommon, occurring in only 2-5% of patients with cancer at necropsy.1 2 Antemortem diagnosis is unlikely unless airways obstruction, severe cough, or haemoptysis occurs. Our personal experience seemed to indicate a more common occurrence and prompted a review of our fibreoptic bronchoscopy records. This review yielded 10 well-documented cases of breast cancer that had metastasised to bronchial mucosa. Methods of specimens was followed. Criteria for classification of slides were those described by Koss.6 Geisinger Medical Center has an active oncology programme including chemotherapy protocols for breast cancer group.bmj.com on June 27, 2017 -Published by http://thorax.bmj.com/ Downloaded from considered positive (classes 4 and 5), while the other diagnosis was verified at thoracotomy (patient 9). The bronchial cytology was negative in four and suspicious (class 3) in four.
The patients ranged in age from 47 to 68 years (mean 56 yr). The time from diagnosis of the primary tumour to documentation of endobronchial metastasis ranged from nine to 61 months (mean 32.4). Four patients had spread to local lymph nodes (one to eight nodes) at the time of their original mastectomy. The mean interval from the time of diagnosis of the primary tumour to discovery of bronchial metastasis was shorter (26 months) for those with deposits in nodes than those without (36 months).
Seven of the patients had postoperative radiotherapy or chemotherapy. There was no difference between them and the three patients with no radiotherapy or chemotherapy.
In eight of the 10 patients it was possible to compare the histology of the metastasis with the primary tumour. In all eight, the histology was similar. In one case the primary tumour was not available for comparison and in the other only cytological proof of metastatic disease was obtained. In the former (case 6), however, the clinical course and response to hormonal management strengthened the diagnosis of metastatic breast carcinoma.
Follow-up on this group of patients as of July 1979, indicated that six patients ( negative. Fibreoptic bronchoscopy demonstrated a thick, oedematous, firm mucosa with total obstruction of the right middle lobe bronchus and 50% narrowing of the right lower lobe bronchus below the takeoff of the superior segment. Biopsy (fig 2) of the right middle and lower lobe mucosa showed an infiltrating adenocarcinoma replacing the mucosa and invading the bronchial smooth muscle. The histology was compatible with the previous primary in the breast. Bronchial cytology was negative. In spite of treatment with radiotherapy to the lung and oral androgen therapy she died at home five months later. CASE 9 The second patient was a 68-year-old woman who underwent a left total mastectomy in April 1973 because of a mucinous infiltrating ductal carcinoma. She received a postoperative course of radiotherapy. In November 1977, she developed pneumonia in the right lower lobe which responded to antibiotics. In May 1978 she again developed right lower lobe pneumonia (fig 3) , this time with associated haemoptysis. After treatment with antibiotics she underwent fibreoptic bronchoscopy on two occasions. A lesion in the right lower lobe bronchus was seen. Two bronchoscopists, suspicious of a bronchial adenoma, were reluctant to biopsy it. A few fragments were obtained during the second procedure. The biopsy was reported as "suspicious of squamous cell carcinoma". The patient subsequently had a thoracotomy with resection of the right lower lobe. Adenocarcinoma (fig 4) compatible with the breast primary was seen obstructing the left lower lobe bronchus. She was last seen in March 1979 with no evidence of recurrence of disease.
Symptoms of metastatic disease were lacking in two patients in whom metastasis was first detected by routine chest radiography. Symptoms in the other eight consisted of cough in seven, dyspnoea There are few studies of diagnostic techniques in breast carcinoma metastatic to the lung. Zavala"l had a yield of 50% using transbronchial lung biopsy in metastatic carcinoma of all types.
Cytological yield with brushing was only 30%. In our series with endobronchial metastasis it appears that deep mucosal biopsies have the highest yield (70%), but bronchial cytology should not be dismissed since it may provide the diagnosis when the biopsy is inadequate, as in two of our cases. Fibreoptic bronchoscopy with deep mucosal biopsy is safe and well tolerated in most patients. Its high yield in the presence of endobronchial disease makes it the procedure of first choice in the evaluation of the patient with suspected endobronchial metastases.
Endobronchial metastasis from breast cancer is not uncommon and should be strongly considered when someone with a history of breast cancer presents with symptoms or radiological findings suggesting endobronchial disease.
